FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer “On April 18, 2024, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following tumor resection in patients with anaplastic...
Radon Gas Exposure May Be Linked to Increased Incidence of Lung Cancer in Nonsmokers“Long-term exposure to radon gas may be associated with a rise in nonsmoking lung cancer cases, according to a recent consumer survey conducted on behalf of The Ohio State University...
Study of Global Lung Cancer Deaths Points to Emerging Trends and Effects on Women “A new study examines the causes of lung and related cancers in the 10 most populous nations, including the U.S. The findings, by researchers at Sylvester Comprehensive Cancer Center,...
Research shows complexity of shared decision-making about lung cancer screening“Patients with multimorbidity and limited life expectancy are often unaware of the risks of lung cancer screening, and clinicians might be hesitant to discuss it, according to a pair of...
Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer“Merck revealed that its Phase III KEYLYNK-006 clinical trial, which tested a combination of Keytruda and Lynparza for...
Nearly half of patients with positive lung cancer screening findings delay follow-up care“Key takeaways: Delaying follow-up after receipt of positive lung cancer screening findings was relatively common. Patients with lung cancer had a high likelihood of clinical...
More News and Updates